Urogen Pharma (URGN)
NASDAQ:URGN

Urogen Pharma (URGN) Stock Forecast & Price Target

318 Followers
See the Price Targets and Ratings of:

URGN Analyst Ratings

Moderate Buy
1Ratings
1 Buy
0 Hold
0 Sell
Based on 1 analysts giving stock ratings to
Urogen
Pharma
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

URGN Stock 12 Months Forecast

Average Price Target

$26.00
▲(203.03% Upside)
Based on 1 Wall Street analysts offering 12 month price targets for Urogen Pharma in the last 3 months. The average price target is $26.00 with a high forecast of $26.00 and a low forecast of $26.00. The average price target represents a 203.03% change from the last price of $8.58.
Highest Price Target$26.00Average Price Target$26.00Lowest Price Target$26.00
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Upgrade Banner
Berenberg Bank
$20.00
Buy
133.10%
Upside
Initiated
UroGen Pharma initiated with a Buy at BerenbergUroGen Pharma initiated with a Buy at Berenberg
Oppenheimer
$21.00
Buy
144.76%
Upside
Reiterated
UroGen Pharma (URGN) PT Lowered to $21 at Oppenheimer on Slower Jelmyto Launch, reiterates Outperform Rating, Sees Situation Improving in 2022 and BeyondOppenheimer analyst Leland Gershell lowered the price target on UroGen Pharma (NASDAQ: URGN) to $21.00 (from $30.00) while maintaining a Outperform rating.
Goldman Sachs
$11.00
Hold
28.21%
Upside
Reiterated
UroGen Pharma (URGN) PT Raised to $11 at Goldman SachsGoldman Sachs analyst Paul Choi raised the price target on UroGen Pharma (NASDAQ: URGN) to $11.00 (from $10.00) while maintaining a Neutral rating.
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

URGN Financial Forecast

URGN Earnings Forecast
Next quarter’s earnings estimate for URGN is -$1.05 with a range of -$1.42 to -$0.89. The previous quarter’s EPS was -$1.13. URGN beat its EPS estimate 75.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 52.49% of the time in the same period. In the last calendar year URGN has Outperformed its overall industry.
Next quarter’s earnings estimate for URGN is -$1.05 with a range of -$1.42 to -$0.89. The previous quarter’s EPS was -$1.13. URGN beat its EPS estimate 75.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 52.49% of the time in the same period. In the last calendar year URGN has Outperformed its overall industry.
URGN Sales Forecast
Next quarter’s sales forecast for URGN is $19.10M with a range of $18.00M to $20.90M. The previous quarter’s sales results were $16.10M. URGN beat its sales estimates 0.00% of the time in past 12 months, while its overall industry beat sales estimates 42.83% of the time in the same period. In the last calendar year URGN has Underperformed its overall industry.
Next quarter’s sales forecast for URGN is $19.10M with a range of $18.00M to $20.90M. The previous quarter’s sales results were $16.10M. URGN beat its sales estimates 0.00% of the time in past 12 months, while its overall industry beat sales estimates 42.83% of the time in the same period. In the last calendar year URGN has Underperformed its overall industry.
URGN Analyst Recommendation Trends
In the current month, URGN has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The URGN average analyst price target in the past 3 months is $26.00
In the current month, URGN has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The URGN average analyst price target in the past 3 months is $26.00

URGN Stock Forecast FAQ

What is URGN’s average 12-month price target, according to analysts?
Based on analyst ratings, Urogen Pharma’s 12-month average price target is $26.00.
    What is URGN’s upside potential, based on the analysts’ average price target?
    Urogen Pharma has 203.03% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is URGN a Buy, Sell or Hold?
          Urogen Pharma has a conensus rating of Moderate Buy which is based on 1 buy ratings, 0 hold ratings and 0 sell ratings.
            What is Urogen Pharma’s price target?
            The average price target for Urogen Pharma is $26.00. This is based on 1 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst price target is $26.00 ,the lowest forecast is $26.00. The average price target represents 203.03% Increase from the current price of $8.58.
              What do analysts say about Urogen Pharma?
              Urogen Pharma’s analyst rating consensus is a ‘Moderate Buy. This is based on the ratings of 1 Wall Streets Analysts.

                What's Included in PREMIUM?
                Make informed decisions based on Top Analysts' activity
                Know what industry insiders are buying
                Get actionable alerts from top Wall Street Analysts
                Find out before anyone else which stock is going to shoot up
                Get powerful stock screeners & detailed portfolio analysis